XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.23.2

Revenue (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregated Revenue | The following table presents our disaggregated revenue for the periods presented (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Immune Medicine revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  | $ | 5,508 |  |  | $ | 7,296 |  |  | $ | 12,610 |  |  | $ | 14,409 |
Collaboration revenue |  |  | 17,536 |  |  |  | 15,082 |  |  |  | 26,654 |  |  |  | 28,785 |
Total Immune Medicine revenue |  |  | 23,044 |  |  |  | 22,378 |  |  |  | 39,264 |  |  |  | 43,194 |
MRD revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  |  | 25,882 |  |  |  | 20,282 |  |  |  | 47,309 |  |  |  | 35,086 |
Regulatory milestone revenue |  |  | — |  |  |  | 1,000 |  |  |  | — |  |  |  | 4,000 |
Total MRD revenue |  |  | 25,882 |  |  |  | 21,282 |  |  |  | 47,309 |  |  |  | 39,086 |
Total revenue |  | $ | 48,926 |  |  | $ | 43,660 |  |  | $ | 86,573 |  |  | $ | 82,280 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration